Advertisement
Canadian Journal of Cardiology

From Improving Survival to Cost Savings for the Health System—Remote Monitoring for All?

Published:February 09, 2022DOI:https://doi.org/10.1016/j.cjca.2022.01.032
      Remote monitoring of cardiac implantable electronic devices (CIEDs) improves patient outcomes across a variety of metrics, from shortening the time to diagnosis of arrhythmias to reducing cardiovascular hospitalizations.
      • Varma N.
      • Epstein A.E.
      • Irimpen A.
      • Schweikert R.
      • Love C.
      TRUST Investigators
      Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial.
      • Crossley G.H.
      • Chen J.
      • Choucair W.
      • et al.
      Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.
      • Tajstra M.
      • Sokal A.
      • Gadula-Gacek E.
      • et al.
      Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator.
      • Piccini J.P.
      • Mittal S.
      • Snell J.
      • et al.
      Impact of remote monitoring on clinical events and associated health care utilization: a nationwide assessment.
      Large observational studies and trials have also demonstrated a potential survival advantage with remote monitoring.
      • Hindricks G.
      • Taborsky M.
      • Glikson M.
      • et al.
      Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.
      • Parthiban N.
      • Esterman A.
      • Mahajan R.
      • et al.
      Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes.
      • Varma N.
      • Piccini J.P.
      • Snell J.
      • et al.
      The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients.
      Although studies largely support cost-effectiveness of a remote monitoring strategy compared with in-office visits alone, literature demonstrating cost-effectiveness and/or savings in a Canadian single-payer public health care context is missing. Existing studies do not use real-world data and lack sufficient granularity on hospitalizations and emergency department visits.
      • Health Quality O.
      Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Varma N.
        • Epstein A.E.
        • Irimpen A.
        • Schweikert R.
        • Love C.
        • TRUST Investigators
        Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial.
        Circulation. 2010; 122: 325-332
        • Crossley G.H.
        • Chen J.
        • Choucair W.
        • et al.
        Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.
        J Am Coll Cardiol. 2009; 54: 2012-2019
        • Tajstra M.
        • Sokal A.
        • Gadula-Gacek E.
        • et al.
        Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator.
        Europace. 2020; 22: 769-776
        • Piccini J.P.
        • Mittal S.
        • Snell J.
        • et al.
        Impact of remote monitoring on clinical events and associated health care utilization: a nationwide assessment.
        Heart Rhythm. 2016; 13: 2279-2286
        • Hindricks G.
        • Taborsky M.
        • Glikson M.
        • et al.
        Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.
        Lancet. 2014; 384: 583-590
        • Parthiban N.
        • Esterman A.
        • Mahajan R.
        • et al.
        Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes.
        J Am Coll Cardiol. 2015; 65: 2591-2600
        • Varma N.
        • Piccini J.P.
        • Snell J.
        • et al.
        The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients.
        J Am Coll Cardiol. 2015; 65: 2601-2610
        • Health Quality O.
        Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment.
        Ont Health Technol Assess Ser. 2018; 18: 1-199
        • Chew D.S.
        • Zarrabi M.
        • You I.
        • et al.
        Clinical and economic outcomes associated with remote monitoring for cardiac implantable electronic devices: a population-based analysis.
        Can J Cardiol. 2022; 38: 736-744
        • Lindvall C.
        • Chatterjee N.A.
        • Chang Y.
        • et al.
        National trends in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.
        Circulation. 2016; 133: 273-281
        • Sapp J.A.
        • Gillis A.M.
        • AbdelWahab A.
        • et al.
        Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study.
        CMAJ Open. 2021; 9: e53-61
        • Baranchuk A.
        • Refaat M.M.
        • Patton K.K.
        • et al.
        Cybersecurity for cardiac implantable electronic devices: what should you know?.
        J Am Coll Cardiol. 2018; 71: 1284-1288

      Linked Article